Most Prostate Cancer Specialists Don't Recommend Active Surveillance for Low-Risk Patients
Wolters Kluwer Health: LippincottSpecialists who treat prostate cancer agree that active surveillance is an effective option—yet most don't recommend it when appropriate for their own patients, according to a study in the July issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.